Journal of Child

SUBMITINFORMATION
EnglishTürkçe

Research Article


DOI :10.26650/jchild.2021.1.810639   IUP :10.26650/jchild.2021.1.810639    Full Text (PDF)

Anafilaksi, çocuk, besin alerjsi, adrenalin oto-enjektörü

Pınar Yılmazbaş, Deniz Özçeker, Onur Adıgüzel, Özlem Terzi

Objective: Anaphylaxis is a systemic reaction that can be fatal if not treated quickly and correctly. The aim of our study is to share the demographic characteristics, clinical course and triggering factors of the cases diagnosed with anaphylaxis in the pediatric allergy outpatient clinic.

Material and Method: The files of the cases with a diagnosis of anaphylaxis who were examined in the pediatric allergy outpatient clinic between the years 2017-2020, were evaluated retrospectively.

Results: The average age of the 57 anaphylaxis cases included in our study was 7.8±4.5 years, 56.1% were male. Of the cases, 68.4% were atopic, 49.1% had elevated serum IgE levels and 36.8% were accompanied by eosinophilia. Triggering allergens were foods (40.4%), drugs (35.1%) and venom (5.3%) respectively. Mild anaphylaxis was observed in 64.9% of cases. It was observed that accompanying allergic diseases, asthma and presence of atopy increased the severity of anaphylaxis. Two or more anaphylaxis attacks were observed in nine cases. None of the cases, who were prescribed adrenaline auto-injector, used the adrenaline autoinjector during the attack.

Conclusion: Anaphylaxis cases are more common in boys. The most common triggering factor is food. Asthma, concomitant allergic diseases and the presence of atopy are factors that increase the severity of attacks. Adrenaline auto-injector is not used in cases where it has been prescribed.

Keywords: Anaphylaxis, child, food allergy, adrenaline auto-injector
DOI :10.26650/jchild.2021.1.810639   IUP :10.26650/jchild.2021.1.810639    Full Text (PDF)

Korkulu Rüya Anafilaksi: Tek Merkez Deneyimi

Pınar Yılmazbaş, Deniz Özçeker, Onur Adıgüzel, Özlem Terzi

Amaç: Anafilaksi hızlı ve doğru müdahale edilmediğinde ölümcül olabilen sistemik bir reaksiyondur. Çalışmamızın amacı çocuk alerji polikliniğine anafilaksi nedeni ile başvurmuş olan hastaların demografik özellikleri, klinik seyri ve tetikleyici etkenlerini paylaşmaktır.

Gereç ve Yöntem: 2017-2020 yılları arasında anafilaksi tanısı ile çocuk alerji polikliniğinde tetkik edilmiş olan hastaların dosyaları geriye dönük olarak değerlendirildi.

Bulgular: Çalışmamıza dahil edilen 57 anafilaksi hastasının yaş ortalaması 7,8±4,5 yıl idi, %56,1’i erkekti. Hastaların %68,4’ü atopik idi, %49,1’inde serum IgE yüksekliği, %36,8’inde eozinofili eşlik etmekteydi. Tetikleyici olduğu belirlenen alerjenler sırasıyla besinler (%40,4), ilaçlar (%35,1) ve venom (%5,3) idi. Hastaların %64,9’unda hafif şiddette anafilaksi gözlendi. Eşlik eden ek alerjik hastalık, astım ve atopi varlığının anafilaksi şiddetini arttırdığı görüldü. Dokuz hastada 2 veya daha fazla anafilaksi atağı gözlenmiş idi. Adrenalin oto-enjektörü reçete edilmiş olan hiçbir hastada atak esnasında oto-enjektör kullanılmamıştı.

Sonuç: Anafilaksi erkek çocuklarda daha sık görülmektedir. En sık tetikleyici etken besinlerdir. Astım, eşlik eden alerjik hastalık ve atopi varlığı atak şiddetini arttıran etmenlerdir. Adrenalin oto-enjektörü reçete edilmiş olan hastalarda da kullanılmamaktadır

Keywords: Anafilaksi, çocuk, besin alerjsi, adrenalin oto-enjektörü

PDF View

References

  • 1. Anagnostu K. Anaphylaxis in children: epidemiology, risk factors and management. Curr Pediatr Rev 2018;14(3):180-186. doi: 10. 2174/1573396314666180507115115 google scholar
  • 2. Lee S, Hess EP, Lohse C, Gilani W, Chamberlain AM, Campbell RL. Trends, characteristics, and incidence of anaphylaxis in 2001-2010: A population-based study. J Allergy Clin Immunol 2017;139(1):182- 8. doi: 10.1016/j.jaci.2016.04.029 google scholar
  • 3. Rudders SA, Arias SA, Camargo CA Jr. Trends in hospitalizations for food-induced anaphylaxis in US children, 2000-2009. J Allergy Clin Immunol 2014;134(4):960-2. doi: 10.1016/j.jaci.2014.06.018 google scholar
  • 4. Tejedor-Alanso MA, Moro Moro M, Mugica Garcia MV. Epidemiology of anaphylaxis: contributions from the last 10 years. Clin Exp Allergy 2015;45(6):1027-39. doi: 10.1111/cea.12418 google scholar
  • 5. Muraro A, Roberts G, Worm M, Bilo MB, Brockow K, Rivas FM, et al. Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology. Allergy 2014;69(8):1026-45. doi: 10.1111/ all.12437 google scholar
  • 6. Grabenhenrich LB, Dölle S, Moneret-Vautin A, Köhli A, Lange L, Sprinder T, et al. Anaphylaxis in children and adolescents: The European Anaphylaxis Registry. J Allergy Clin Immunol 2016;137(4):1128-37. doi: 10.1016/j.jaci.2015.11.015 google scholar
  • 7. Dogru M, Bostancı I, Ozmen S, Ginis T, Şenol H.D. The features of anaphylaxis cases followed in the pediatric allergy clinic. J Curr Pediatr 2017;15:12-8. doi:10.4274/jcp.58070 google scholar
  • 8. Sampson HA, Munoz-Furlong A, Campbell RL, Adkinson NF, Bock SA, Branum A, et al. Second symposium on the definition and management of anaphylaxis: summary report Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol 2006;47(4):373-80. doi: 10.1016/j.jaci.2005.12.1303 google scholar
  • 9. Orhan F, Civelek E, Şahiner ÜM, Arga M, Can D, Çalıkaner AZ, et al. Anaphylaxis: Turkish National Guideline 2018. Asthma Allergy Immunology 2018;16. doi:10.21911/aai.2018.1 google scholar
  • 10. De Swert LF, Bullens D, Raes M, Dermaux AM. Anaphylaxis in referred pediatric patients: demographic and clinical features, triggers, and therapeutic approach. Eur J Pediatr 2008;167:1251- 61. doi: 10.1007/s00431-007-0661-2 google scholar
  • 11. Vezir E, Erkoçoğlu M, Kaya A, Toyran M, Özcan C, Akan A, et al. Characteristics of anaphylaxis in children referred to a tertiarty care center. Allergy Asthma Proc 2013;34:239-46. doi: 10.2500/ aap.2013.34.3654 google scholar
  • 12. Huang F, Chawla K, Jarvinen KM, et al. Anaphylaxis in a New York City pediatric emergency department: triggers, treatments, and outcomes. J Allergy Clin Immunol 2012;129(1):162-8, e1-3. doi: 10.1016/j.jaci.2011.09.018 google scholar
  • 13. Astier C, Morisset M, Roitel. Predictive value of skin prick tests using recombinant allergens for diagnosis of peanut allergy. J Allergy Clin Immunol 2006;118(1):250-6. doi: 10.1016/j.jaci.2006.04.053 google scholar
  • 14. Bock SA, Munoz-Furlong A, Sampson HA. Fatalities due to anaphylactic reactions to foods. J Allergy Clin Immunol 2001;107(1):191-3. doi: 10.1067/mai.2001.112031 google scholar
  • 15. Commins SP. Outpatient Emergencies: Anaphylaxis. Med Clin North Am 2017;101(3):521-36. doi: 10.1016/j.mcna.2016.12.003 google scholar
  • 16. Thong BY, Cheng YK, Leong KP, Tang CY, Chng HH. Anaphylaxis in adults referred to a clinical immunology/allergy centre in Singapore. Singapore Med J 2005;46:529-34. google scholar
  • 17. Hoffer V, Scheuerman O, Marcus N, Levy Y, Segal N, Lagovsky I, et al. Anaphylaxis in Israel: experience with 92 hospitalized children. Pediatr Allergy Immunol 2010;22:172-7. doi: 10.1111/j.1399- 3038.2010.00990 google scholar
  • 18. Alves B, Sheikh A. Age-spesific aetiology of anaphylaxis. Arch Dis Child 2001;85:349. doi: 10.1136/adc.85.4.348b google scholar
  • 19. Simons FER. Anaphylaxis. J Allergy Clin Immunol 2010;125:S161-81. doi:10.1016/j.jaci.2009.12.981 google scholar
  • 20. Shreffler WG, Beyer K, Chu T-HT, Burks AW, Sampson HA. Microarray immunoassay: association of clinical history, in vitro IgE function, and heterogeneity of allergenic peanut epitopes. J Allergy Clin Immunol 2004;113(4):776-82. doi: 10.1016/j.jaci.2003.12.588 google scholar

Citations

Copy and paste a formatted citation or use one of the options to export in your chosen format


EXPORT



APA

Yılmazbaş, P., Özçeker, D., Adıgüzel, O., & Terzi, Ö. (2021). Anafilaksi, çocuk, besin alerjsi, adrenalin oto-enjektörü. Journal of Child, 21(1), 42-47. https://doi.org/10.26650/jchild.2021.1.810639


AMA

Yılmazbaş P, Özçeker D, Adıgüzel O, Terzi Ö. Anafilaksi, çocuk, besin alerjsi, adrenalin oto-enjektörü. Journal of Child. 2021;21(1):42-47. https://doi.org/10.26650/jchild.2021.1.810639


ABNT

Yılmazbaş, P.; Özçeker, D.; Adıgüzel, O.; Terzi, Ö. Anafilaksi, çocuk, besin alerjsi, adrenalin oto-enjektörü. Journal of Child, [Publisher Location], v. 21, n. 1, p. 42-47, 2021.


Chicago: Author-Date Style

Yılmazbaş, Pınar, and Deniz Özçeker and Onur Adıgüzel and Özlem Terzi. 2021. “Anafilaksi, çocuk, besin alerjsi, adrenalin oto-enjektörü.” Journal of Child 21, no. 1: 42-47. https://doi.org/10.26650/jchild.2021.1.810639


Chicago: Humanities Style

Yılmazbaş, Pınar, and Deniz Özçeker and Onur Adıgüzel and Özlem Terzi. “Anafilaksi, çocuk, besin alerjsi, adrenalin oto-enjektörü.” Journal of Child 21, no. 1 (Nov. 2024): 42-47. https://doi.org/10.26650/jchild.2021.1.810639


Harvard: Australian Style

Yılmazbaş, P & Özçeker, D & Adıgüzel, O & Terzi, Ö 2021, 'Anafilaksi, çocuk, besin alerjsi, adrenalin oto-enjektörü', Journal of Child, vol. 21, no. 1, pp. 42-47, viewed 15 Nov. 2024, https://doi.org/10.26650/jchild.2021.1.810639


Harvard: Author-Date Style

Yılmazbaş, P. and Özçeker, D. and Adıgüzel, O. and Terzi, Ö. (2021) ‘Anafilaksi, çocuk, besin alerjsi, adrenalin oto-enjektörü’, Journal of Child, 21(1), pp. 42-47. https://doi.org/10.26650/jchild.2021.1.810639 (15 Nov. 2024).


MLA

Yılmazbaş, Pınar, and Deniz Özçeker and Onur Adıgüzel and Özlem Terzi. “Anafilaksi, çocuk, besin alerjsi, adrenalin oto-enjektörü.” Journal of Child, vol. 21, no. 1, 2021, pp. 42-47. [Database Container], https://doi.org/10.26650/jchild.2021.1.810639


Vancouver

Yılmazbaş P, Özçeker D, Adıgüzel O, Terzi Ö. Anafilaksi, çocuk, besin alerjsi, adrenalin oto-enjektörü. Journal of Child [Internet]. 15 Nov. 2024 [cited 15 Nov. 2024];21(1):42-47. Available from: https://doi.org/10.26650/jchild.2021.1.810639 doi: 10.26650/jchild.2021.1.810639


ISNAD

Yılmazbaş, Pınar - Özçeker, Deniz - Adıgüzel, Onur - Terzi, Özlem. “Anafilaksi, çocuk, besin alerjsi, adrenalin oto-enjektörü”. Journal of Child 21/1 (Nov. 2024): 42-47. https://doi.org/10.26650/jchild.2021.1.810639



TIMELINE


Submitted14.10.2020
Accepted04.03.2021
Published Online17.05.2021

LICENCE


Attribution-NonCommercial (CC BY-NC)

This license lets others remix, tweak, and build upon your work non-commercially, and although their new works must also acknowledge you and be non-commercial, they don’t have to license their derivative works on the same terms.


SHARE




Istanbul University Press aims to contribute to the dissemination of ever growing scientific knowledge through publication of high quality scientific journals and books in accordance with the international publishing standards and ethics. Istanbul University Press follows an open access, non-commercial, scholarly publishing.